135 related articles for article (PubMed ID: 6853588)
1. Studies on the tumor-inhibiting efficacy of Iscador in experimental animal tumors.
Berger M; Schmähl D
J Cancer Res Clin Oncol; 1983; 105(3):262-5. PubMed ID: 6853588
[TBL] [Abstract][Full Text] [Related]
2. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
Kuttan G; Menon LG; Kuttan R
Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study on antitumor effect of an extract derived from Patrinia scabra Bge].
Zhang YX
Zhong Xi Yi Jie He Za Zhi; 1984 Feb; 4(2):109-11. PubMed ID: 6235038
[No Abstract] [Full Text] [Related]
4. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
5. [The plants of Siberia and the Far East--sources in the search for drug preparations for oncological practice].
Amosova EN; Zueva EP; Gol'dberg ED
Farmakol Toksikol; 1991; 54(6):3-7. PubMed ID: 1804689
[TBL] [Abstract][Full Text] [Related]
6. [The potential use of an extract of aspen bark for enhancing the efficacy of specific treatment methods in experimental malignant neoplasms].
Razina TG; Krylova SG; Zueva EP; Amosova EN; Turetskova VF
Eksp Klin Farmakol; 1998; 61(6):42-4. PubMed ID: 9929816
[TBL] [Abstract][Full Text] [Related]
7. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
[No Abstract] [Full Text] [Related]
8. Iscador.
CA Cancer J Clin; 1983; 33(3):186-8. PubMed ID: 6404528
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lung metastasis by adoptive immunotherapy using Iscador.
Antony S; Kuttan R; Kuttan G
Immunol Invest; 1999 Jan; 28(1):1-8. PubMed ID: 10073677
[TBL] [Abstract][Full Text] [Related]
11. Where are cancer survivors in the Iscador study?
Yarger L
Altern Ther Health Med; 2001; 7(4):18. PubMed ID: 11452558
[No Abstract] [Full Text] [Related]
12. Iscador update: interview with Robert Gorter, M.D. Interview by Fred Gardner.
Gorter R
AIDS Treat News; 1998 Oct; (No 304):7-8 contd. PubMed ID: 11365865
[TBL] [Abstract][Full Text] [Related]
13. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
[TBL] [Abstract][Full Text] [Related]
14. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
15. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
Salzer G
Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
[TBL] [Abstract][Full Text] [Related]
16. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
Kuttan G; Vasudevan DM; Kuttan R
J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
[TBL] [Abstract][Full Text] [Related]
17. Presence of a receptor for the active component of Iscador in ascites fluid of tumour bearing mice.
Kuttan G; Vasudevan DM; Kuttan R
Cancer Lett; 1989 Dec; 48(3):223-7. PubMed ID: 2605571
[TBL] [Abstract][Full Text] [Related]
18. Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).
Kuttan G; Vasudevan DM; Kuttan R
Cancer Lett; 1988 Aug; 41(3):307-14. PubMed ID: 3409209
[TBL] [Abstract][Full Text] [Related]
19. Role of natural killer cells in iscador mediated inhibition of metastasis by adoptive immunotherapy.
Antony S; Kuttan R; Kuttan G
Immunol Invest; 2000 Aug; 29(3):219-31. PubMed ID: 10933606
[TBL] [Abstract][Full Text] [Related]
20. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
